Case report: Long-lasting SARS-CoV-2 infection with post-COVID-19 condition in two patients with chronic lymphocytic leukemia: The emerging therapeutic role of casirivimab/imdevimab

Overview of attention for article published in Frontiers in oncology, September 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

So far, Altmetric has seen 66 X posts from 59 X users, with an upper bound of 208,767 followers.

RT @atranscendedman: @NohaAboelataMD @US_FDA Most studies predate the FDA limitation. But there's others like https://t.co/7goDpifR7Q and h…

@NohaAboelataMD @US_FDA Most studies predate the FDA limitation. But there's others like https://t.co/7goDpifR7Q and https://t.co/nTHNDHQ8MC. Very likely that we will see AV + mAb as the initial cohort of treatments. Question is...which ones? mAb seems pro

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 62 additional X posts.